Literature DB >> 29656466

Evaluation of high-fat high-fructose diet treatment in factor VIII (coagulation factor)-deficient mouse model.

Alaknanda Mishra1, Shailendra Arindkar1, Preeti Sahay1, Jerald Mahesh Kumar2, Pramod K Upadhyay1, Subeer S Majumdar1, Perumal Nagarajan1.   

Abstract

Non-alcoholic fatty liver disease (NAFLD)-like conditions enhance the production and action of clotting factors in humans. However, studies examining the effect of NAFLD due to high-fat high-fructose (HFHF) diet in factor VIII-deficient (haemophilia A) animals or patients have not been reported previously. In this study, we investigated the individual role of factor VIII in the progression of diet-induced NAFLD in the factor 8-/- (F8-/- ) mouse model system and its consequences on the haemophilic status of the mice. The F8-/- mice were fed with HFHF diet for 14 weeks. Physiological, biochemical, haematological, molecular, pathological, and immune histochemical analyses were performed to evaluate the effect of this diet. The F8-/- mice developed hepatic steatosis after 14 weeks HFHF diet and displayed lower energy metabolism, higher myeloid cell infiltration in the liver, decreased platelet count, upregulated de novo fatty acid synthesis, lipid accumulation, and collagen deposition. This study helps to understand the role of factor VIII in NAFLD pathogenesis and to analyse the severity and consequences of steatosis in haemophilic patients as compared to normal population. This study suggests that haemophilic animals (F8-/- mice) are highly prone to hepatic steatosis and thrombocytopenia.
© 2018 The Authors. International Journal of Experimental Pathology © 2018 International Journal of Experimental Pathology.

Entities:  

Keywords:  factor 8−/−; haemophilia A; high-fat high-fructose; metabolism; non-alcoholic fatty liver disease

Mesh:

Substances:

Year:  2018        PMID: 29656466      PMCID: PMC5917390          DOI: 10.1111/iep.12264

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  21 in total

1.  Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis.

Authors:  Bo Xu; Ulrika Broome; Mehmet Uzunel; Silvia Nava; Xupeng Ge; Makiko Kumagai-Braesch; Kjell Hultenby; Birger Christensson; Bo-Göran Ericzon; Jan Holgersson; Suchitra Sumitran-Holgersson
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

2.  Impact of being underweight or overweight on factor VIII dosing in hemophilia A patients.

Authors:  Séverine Henrard; Niko Speybroeck; Cedric Hermans
Journal:  Haematologica       Date:  2013-05-03       Impact factor: 9.941

Review 3.  Coagulation disorders in liver disease.

Authors:  Lucio Amitrano; Maria A Guardascione; Vincenzo Brancaccio; Antonio Balzano
Journal:  Semin Liver Dis       Date:  2002-02       Impact factor: 6.115

Review 4.  Overweight and obesity in hemophilia: a systematic review of the literature.

Authors:  Trisha E Wong; Suvankar Majumdar; Elizabeth Adams; Sarah Bergman; Mary Lou Damiano; Joann Deutsche; Michael Recht
Journal:  Am J Prev Med       Date:  2011-12       Impact factor: 5.043

5.  Transplantation of endothelial cells corrects the phenotype in hemophilia A mice.

Authors:  V Kumaran; D Benten; A Follenzi; B Joseph; R Sarkar; S Gupta
Journal:  J Thromb Haemost       Date:  2005-09       Impact factor: 5.824

6.  Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression.

Authors:  Masashi Miyao; Hirokazu Kotani; Tokiko Ishida; Chihiro Kawai; Sho Manabe; Hitoshi Abiru; Keiji Tamaki
Journal:  Lab Invest       Date:  2015-07-27       Impact factor: 5.662

7.  Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).

Authors:  Siddharth Verma; Donald Jensen; John Hart; Smruti R Mohanty
Journal:  Liver Int       Date:  2013-06-13       Impact factor: 5.828

8.  A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII.

Authors:  Scot A Fahs; Matthew T Hille; Qizhen Shi; Hartmut Weiler; Robert R Montgomery
Journal:  Blood       Date:  2014-04-04       Impact factor: 22.113

Review 9.  The complex myeloid network of the liver with diverse functional capacity at steady state and in inflammation.

Authors:  Christoph Eckert; Niklas Klein; Miroslaw Kornek; Veronika Lukacs-Kornek
Journal:  Front Immunol       Date:  2015-04-20       Impact factor: 7.561

10.  Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels.

Authors:  Klytaimnistra Kiouptsi; Alexandra Grill; Amrit Mann; Mareike Döhrmann; Maren Lillich; Sven Jäckel; Frano Malinarich; Henning Formes; Davit Manukyan; Saravanan Subramaniam; Avinash Khandagale; Cornelia Karwot; Serge C Thal; Markus Bosmann; Inge Scharrer; Kerstin Jurk; Christoph Reinhardt
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.